OPTOMED — Optomed Oyj Cashflow Statement
0.000.00%
- €67.77m
- €61.11m
- €15.04m
Annual cashflow statement for Optomed Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.18 | -4.25 | -5.47 | -4.44 | -5.45 |
Depreciation | |||||
Non-Cash Items | -0.098 | 0.456 | -0.275 | 0.664 | 0.066 |
Other Non-Cash Items | |||||
Changes in Working Capital | -1.7 | -1.84 | 0.232 | 0.968 | 1.29 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.8 | -2.94 | -2.37 | -0.616 | -1.6 |
Capital Expenditures | -1.82 | -2.57 | -3.03 | -2.41 | -2.12 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.001 | — | — | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.82 | -2.57 | -3.03 | -2.41 | -2.12 |
Financing Cash Flow Items | 0 | — | -0.682 | -0.318 | -0.554 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3.7 | 1.64 | 7 | 1.61 | 7.08 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -8.26 | -3.8 | 1.72 | -1.41 | 3.35 |